• A technical solution to a technical problem: the invention must solve a clearly identified technical problem.
  • Novelty: the software must be new and not previously disclosed to the public.
  • Inventive step: the software must involve an inventive step—it cannot be a mere obvious combination of known elements.
  • Industrial applicability: the software must have a practical industrial application.

By way of illustration, a decision by the Boards of Appeal of the European Patent Office confirmed that the use of a neural network to monitor heartbeat signals and detect irregularities constituted a technical invention (Decision T 0598/07 of 19/05/2010).

Enforcing software patents presents unique challenges.
To prove infringement, it is often necessary to analyze the source code of the alleged infringer in order to determine whether the patented features have been implemented.
In France, for example, this typically requires organizing an infringement seizure (“saisie-contrefaçon”) to access the source code and gather the evidence needed to initiate legal proceedings.

Engaging an expert in intellectual property and software analysis is a crucial step in identifying and proving patent infringement.

Technical expertise is essential to establish a correspondence between the patented invention and the technology used by a third party—an element that is often decisive in enforcing industrial property rights.

Artificial intelligence (AI) technologies are now at the core of innovation strategies across all industries. This momentum is reflected in the exponential growth of AI-related patent applications worldwide, particularly in areas such as computer vision, natural language processing, and predictive systems.

China is leading this race in terms of filing volume, ahead of the United States, South Korea, and Europe. This trend highlights a major shift: AI is no longer just a technology of the future—it has become a strategic asset that must be protected.

Yet in Europe, and in France in particular, misconceptions persist regarding the patentability of AI-related inventions, which are often mistakenly seen as excluded from patent protection. In reality, it is entirely possible to obtain patents for technical solutions involving or leveraging AI, provided that certain patentability requirements are met.

To maximize the chances of obtaining a patent, we advise to:
  • Demonstrate that the invention is non-obvious, i.e., that it involves an inventive step beyond known techniques.
  • Provide a detailed description of the AI model used, including its structure, training method, and implementation.
  • Explain how the functioning of the AI provides a technical solution to a clearly identified problem.

While inventions involving artificial intelligence can be protected by patents, their treatment by intellectual property offices raises several technical, legal, and strategic challenges that should be anticipated as early as the development phase.
Here are the main points to watch in your IP strategy:

Do Not Underestimate the Classic Patentability Criteria

Even in a cutting-edge field like AI, the fundamental patentability criteria remain essential: novelty, inventive step, industrial applicability, and—most importantly—the technical character of the invention.
AI “as such” is not patentable, but a technical solution that uses AI to solve a technical problem can be.

Clearly Explain the Technical Contribution in the Patent Application

Patent offices—particularly the EPO—pay close attention to the clarity of the technical contribution:
What technical problem is being solved? By what technical means? How does the AI play a decisive role beyond that of a generic tool?

Clarify Data Ownership for AI Training Purposes

Training an AI model often relies on large-scale datasets. However, these datasets may be protected by copyright or sui generis database rights.
Using such data without the explicit consent of the rights holder may constitute infringement and expose you to serious consequences, such as:

  • Significant damages, potentially including lost profits and moral prejudice;
  • Court-ordered bans on the use or commercialization of AI models trained unlawfully.

As a result, the entire AI value chain may be compromised, even if the system performs well from a technical standpoint.

Secure Rights to AI Contributions from the Outset

A key legal issue specific to AI-generated inventions concerns the designation of the inventor.
As of today, neither the EPO nor the USPTO accepts an AI system as an inventor. Only a natural person may be named. It is therefore standard practice to designate the researcher or engineer who designed and trained the AI as the inventor.

Open-Source Licenses: Hidden Constraints for IP Strategy

There are two main types of open-source licenses:

  • Permissive licenses allow for reuse in creating proprietary code, with minimal restrictions.
  • In contrast, copyleft licenses require that if you integrate copyleft code into your own, the entire resulting codebase must be made public. As a result, you lose ownership of the associated intellectual property rights.
Technical context

A company specializing in medical devices has developed an AI-based diagnostic support system designed for the automated analysis of radiological images (MRI, CT scans).

Functioning of the Invention

The system includes:

  • an image preprocessing module;
  • a deep learning model trained to detect specific anomalies (e.g., microcalcifications, tumors);
  • a user interface enabling physicians to view the results, with a reliability score associated with each detection.
Patentability Justification
  • The technical problem is clearly defined: improving the reliability and speed of diagnosing complex anomalies that are not visible to the naked eye.
  • AI provides a technical solution: the integration of an AI algorithm trained on clinical datasets to deliver interpretive assistance, including automated precision scoring.
  • There is a clear link between the AI and the technical purpose: the AI is not merely a statistical analysis tool—it is an integral part of a technical process with proven medical utility.

Since the technical contribution was deemed to go beyond a mere implementation of an abstract algorithm, the patent was granted by the EPO.

May 2025

Adrien Bétrancourt

Partner | European Patent Attorney